MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...
Real-world results: Swiss hospitals saw strong mental health improvements in patients given LSD or psilocybin with psychotherapy under a compassionate use program. Safe in clinics: No serious side ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...
Dr Albert Hofmann accidentally discovered the hallucinatory effects of LSD in April 1943. In 1986, he told the BBC about a "terrifying" bicycle ride home from the laboratory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results